Contact Us
UBC Insights

Insights from
UBC's Expert Voices

Featured Updates

Featured Image
Blog
December 3, 2025 7 min read

2025 NORD Rare Disease Summit: Advancing Evidence and Partnerships for the Rare Community
UBC attended the 2025 NORD Rare Diseases & Orphan Products Breakthrough Summit, where patient voices, scientific innovation, and regulatory expertise converged to shape the future of rare-disease research. Learn what inspired us and how we’re advancing real-world evidence, patient partnerships, and innovative trial designs to accelerate progress for the rare-disease community.
Julie Shutt
Associate Director, Patient Engagement
cell and gene, dna
Blog
November 21, 2025 5 min read

High-Touch, High-Impact: Optimizing Patient Support in Cell & Gene Therapy
As cell and gene therapies reshape treatment paradigms, patient support programs must evolve to meet new challenges. Discover how strategic alignment, payer advocacy, and innovative solutions can optimize the patient journey.
Dana Edwards
Vice President, Patient Access & Strategic Engagement
lightbulb in center
Blog
November 19, 2025 6 min read

Registry feasibility assessments for post-authorization safety studies (PASS): Learnings and Challenges
UBC recently completed a multi-country feasibility assessment to identify disease registries capable of supporting a PASS for a novel therapy targeting a hereditary muscular disorder. The study evaluated registry data elements, quality, and governance to ensure fit-for-purpose real-world data (RWD) for generating reliable RWE.

Posts by Date

Diverse Team Of Data Scientists Analyzing Information.
Blog
July 29, 2024 5 min read

ICH/FDA Draft Guidance on RWD Safety Studies Highlight Their Increased Importance
Understand the latest international opinion on the plan, design, and analysis of pharmacoepidemiological safety studies using RWD.
Concept of choice showing two arrows going different directions
Blog
July 22, 2024 9 min read

Enhance Your Pharmacovigilance and Regulatory Compliance with Expert PV System Transition Management and Seamless Migration
Whether your transition includes a vendor change, acquisition, or portfolio expansion, UBC makes it easy to transition your system.
Data overlaying a busy street corner in a downtown city
Blog
June 24, 2024 4 min read

RWD Enrichment Studies: Linking Pre- and Post-Trial Data Utilizing Tokenization
Clinical trials provide a limited view of patient experience but this can be expanded through tokenization to link pre- and post-trial data.
Technology image depicting the cloud and connection points
Blog
June 7, 2024 5 min read

Pharmacovigilance Tableau Data Analytics Platform: All-in-One Dashboard System for PV Metrics and KPIs
The UBC PV Tableau Data Analytics Platform provides an all-in-one dashboard system for safety Key Performance Indicators (KPIs) analysis and compliance oversight.
Data waves showcasing pinpoints and how people are connected
Blog
May 30, 2024 1 min read

Data Liquidity for Clinical Trials: Patient Autonomy and the Rise of AI
UBC and Seqster talked with Chilmark Research about the power of patient-mediated electronic medical record release.
Man working on computer setting up a folder structure and data network
Blog
May 28, 2024 5 min read

Pharmacovigilance Case Automation Platform: Cost-Efficient Solution to Manage Increased Case Volume
UBC’s PV case automation platform is purpose-built with a focus on customizing our technology for your specific product and program needs.
The Wynn Las Vegas hotel.
Blog
May 13, 2024 6 min read

UBC Perspectives from Asembia’s AXS24 Summit
Patient services are undergoing rapid changes based on regulatory requirements and evolving patient and prescriber expectations.
Woman using chatbot in computer to automate her request
Blog
April 29, 2024 5 min read

The Use of AI/ChatGPT in the Preparation of Aggregate Safety Reports & Signal Management Activities
At UBC, we share a vision where AI and safety writing come together to forge a safer path.
Man and woman having discussion overlooking data on computer
Blog
April 19, 2024 3 min read

Experience the Difference with UBC’s REMS Professionals
At UBC, we are committed to our continued partnership with our customers and to providing exceptional work on behalf of our patients
1 … 3 4 5 6 7 … 17

Press Inquires

Want to know more about us?

Subscribe Now

Want to know more about us?

Subscribe Now

About us

Solutions

Insights

Resources

For HCPs

Clinical

Contact us

About UBC

Other

Evidence Development

Safety & Risk Management

Patient Access

Providers

Technology Solutions

The logo for UBC, which features a teal stylized swirling design on the left, followed by "UBC" in the same teal color.
©2025 United BioSource LLC, all rights reserved
UBC®, CLÆRITY®, SæfetyWorks®, ExpressConnect® and UBC Pathways® are trademarks of United BioSource LLC.
Twitter Linkedin
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.